News
Events
中文
Submit RFP
Who we are
Overview
Mission, purpose & values
Leadership & expertise
Where we operate
Our story so far
Corporate accountability
DEI
ESG
Code of conduct
Partners
Investors
Vendor partners
What we do
Overview
Services
Clinical Development
Early phase development
Phase II/III studies
Clinical development expertise
Clinical Operations & Delivery
Study start-up
Patient pathway & feasibility
Regulatory Services & Surveillance
Regulatory services
Pharmacovigilance
Medical writing
Trial Data & Technology
Biometrics and Biostatistics
Clarity
Clinical analytics
Clinical data management
Clinical technology and ecosystem
RBQM
Service models
Therapeutic areas
Cardiology
Gastroenterology
Infectious diseases
Nephrology
Neurology
Oncology
Rare diseases
Respiratory
Women’s health
Quality assurance
Your journey
Overview
Become part of a trial
Partner with us
Careers
Overview
View open positions
Being part of our team
Contact Us
Who we are
Overview
Mission, purpose & values
Leadership & expertise
Where we operate
Our story so far
Corporate accountability
DEI
ESG
Code of conduct
Partners
Investors
Vendor partners
What we do
Overview
Services
Clinical Development
Early phase development
Phase II/III studies
Clinical development expertise
Clinical Operations & Delivery
Study start-up
Patient pathway & feasibility
Regulatory Services & Surveillance
Regulatory services
Pharmacovigilance
Medical writing
Trial Data & Technology
Biometrics and Biostatistics
Clarity
Clinical analytics
Clinical data management
Clinical technology and ecosystem
RBQM
Service models
Therapeutic areas
Cardiology
Gastroenterology
Infectious diseases
Nephrology
Neurology
Oncology
Rare diseases
Respiratory
Women’s health
Quality assurance
Your journey
Overview
Become part of a trial
Partner with us
Careers
Overview
View open positions
Being part of our team
Contact Us
Home
▶
Who we are
▶
Leadership & expertise
▶
Catherine Xie
Catherine Xie
Vice President, Pharmacovigilance
